Stony Brook Experts

Dr. Amy Schattel is an Associate Clinical Professor of Psychiatry and the Director of the Neuromodulation and Treatment Resistant Depression Program at Stony Brook University.  She is a board-certified psychiatrist with specialized training in interventional psychiatry, including transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), ketamine treatments, and neuromodulation-based clinical evaluation. Dr. Schattel completed her psychiatry residency at the Medical University of South Carolina, where she pursued advanced training in brain stimulation modalities and participated in research examining neuromodulation applications. Her clinical and research interests include interventional psychiatry (TMS, Ketamine, ECT, VNC, etc), aerospace medicine and psychiatry topics, and AI.

She adds, "My approach combines the highest standard of evidence-based psychiatric interventions with a commitment to compassionate, patient-centered care. My vision is to advance neuromodulation through research and clinical innovation, integrating proven therapies with emerging treatments in the Neuromodulation Clinic to bring hope and transformative outcomes to the Stony Brook community.”